Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Raw Materials (2020 - 2022)

Rapid Micro Biosystems (RPID) has disclosed Raw Materials for 3 consecutive years, with $12.6 million as the latest value for Q2 2022.

  • Quarterly Raw Materials rose 53.68% to $12.6 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $12.6 million through Jun 2022, up 53.68% year-over-year, with the annual reading at $10.1 million for FY2021, 50.06% up from the prior year.
  • Raw Materials hit $12.6 million in Q2 2022 for Rapid Micro Biosystems, up from $10.9 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $12.6 million in Q2 2022 to a low of $6.8 million in Q4 2020.
  • Historically, Raw Materials has averaged $9.8 million across 3 years, with a median of $10.2 million in 2021.
  • Biggest five-year swings in Raw Materials: soared 50.06% in 2021 and later surged 53.68% in 2022.
  • Year by year, Raw Materials stood at $6.8 million in 2020, then skyrocketed by 50.06% to $10.1 million in 2021, then rose by 23.92% to $12.6 million in 2022.
  • Business Quant data shows Raw Materials for RPID at $12.6 million in Q2 2022, $10.9 million in Q1 2022, and $10.1 million in Q4 2021.